---
schema_version: "secwatch.filing_event.v1"
accession: "0001040130-25-000086"
form_type: "8-K"
ticker: "PETS"
cik: "0001040130"
company_name: "PETMED EXPRESS INC"
filed_at: "2025-11-13T23:59:59+00:00"
generated_at: "2026-05-16T20:06:30.398107+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# PetMed Express warns Q2 net sales down ~25% YoY; receives Nasdaq delisting notice

## Summary
- Preliminary Q2 net sales estimated at $43.4M-$44.5M vs $58.0M (restated) prior year.
- Six-month net sales estimated at $94.5M-$95.6M vs $124.3M (restated) prior year.
- Cannot estimate operating income due to pending goodwill impairment analysis.
- Cash $36.1M, no debt as of September 30, 2025.
- Nasdaq non-compliance for late Q1 and Q2 10-Qs; compliance plan update due by Nov 28, 2025.

## SEC filing metadata
- accession: 0001040130-25-000086
- form_type: 8-K
- ticker: PETS
- cik: 0001040130
- company_name: PETMED EXPRESS INC
- filed_at: 2025-11-13T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 3.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1040130/000104013025000086/0001040130-25-000086-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1040130/000104013025000086/pets-20251112.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001040130-25-000086
- JSON: https://secwatch.observer/filing/0001040130-25-000086.json
- Plain text: https://secwatch.observer/filing/0001040130-25-000086.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.